Updated on 3 June 2013
The company has set up a separate division for new drug and technology development of the whole NCPC Group. Nearly 300 experts and technicians, advanced instruments and integrated pilot units make it possible to transform laboratory reactions into large-scale production.
In recent years, NCPC has continued to increase its investment on R&D and plans to launch a new set of products every year in the market. Recognized as a generic drug manufacturer, NCPC is also striving to be a novel drugdeveloper.
North China Pharmaceutical Company aims to develop a research platform of its own to make new drugs, using chemical technology and modern biotechnology. NCPC has also collaborated with research institutions in China and aboard to introduce various technical and research resources and has formed innovation alliances with industrial, academic and research organizations.